X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3819) 3819
Publication (243) 243
Newsletter (145) 145
Book Review (41) 41
Book Chapter (31) 31
Magazine Article (8) 8
Newspaper Article (4) 4
Dissertation (3) 3
Conference Proceeding (2) 2
Trade Publication Article (2) 2
Book / eBook (1) 1
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2684) 2684
rhabdomyolysis (2588) 2588
male (2063) 2063
female (1279) 1279
adult (1228) 1228
index medicus (1160) 1160
middle aged (876) 876
creatine kinase - blood (805) 805
rhabdomyolysis - etiology (780) 780
rhabdomyolysis - chemically induced (620) 620
aged (510) 510
animals (497) 497
risk factors (473) 473
rhabdomyolysis - diagnosis (470) 470
acute kidney injury - etiology (453) 453
rhabdomyolysis - complications (409) 409
medicine, general & internal (407) 407
acute-renal-failure (378) 378
adolescent (366) 366
rhabdomyolysis - blood (345) 345
diagnosis (310) 310
creatine kinase (308) 308
acute renal failure (302) 302
research (293) 293
urology & nephrology (291) 291
health aspects (287) 287
exercise (284) 284
care and treatment (271) 271
pharmacology & pharmacy (267) 267
rhabdomyolysis - therapy (266) 266
treatment outcome (256) 256
complications and side effects (251) 251
acute kidney injury (250) 250
retrospective studies (232) 232
surgery (230) 230
case studies (222) 222
young adult (211) 211
case report (205) 205
child (204) 204
myoglobin (201) 201
myopathy (199) 199
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (197) 197
statins (188) 188
medicine (181) 181
acute kidney injury - therapy (180) 180
rats (180) 180
creatinine - blood (174) 174
myoglobinuria (172) 172
rhabdomyolysis - physiopathology (169) 169
medicine & public health (167) 167
drug interactions (166) 166
myoglobin - blood (162) 162
acute kidney injury - chemically induced (159) 159
simvastatin (159) 159
diagnosis, differential (156) 156
aged, 80 and over (155) 155
pediatrics (151) 151
biomarkers - blood (149) 149
kidneys (149) 149
rhabdomyolysis - pathology (148) 148
acute disease (147) 147
patients (147) 147
time factors (146) 146
clinical neurology (138) 138
urine (137) 137
metabolism (136) 136
rhabdomyolysis - enzymology (132) 132
mortality (129) 129
muscle, skeletal - pathology (128) 128
veterinary sciences (128) 128
skeletal-muscle (127) 127
analysis (125) 125
creatine (125) 125
abridged index medicus (124) 124
toxicology (124) 124
sport sciences (122) 122
emergency medicine (121) 121
renal dialysis (119) 119
injury (118) 118
causes of (117) 117
muscles (117) 117
physiological aspects (117) 117
blood (116) 116
child, preschool (115) 115
exertional rhabdomyolysis (115) 115
rhabdomyolysis - metabolism (115) 115
acute kidney injury - diagnosis (113) 113
enzymes (113) 113
oxidative stress (113) 113
muscular diseases - chemically induced (112) 112
prospective studies (110) 110
renal failure (109) 109
therapy (108) 108
risk (107) 107
muscle (106) 106
fatal outcome (105) 105
disease (104) 104
drugs (104) 104
failure (104) 104
internal medicine (104) 104
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3654) 3654
French (73) 73
Japanese (63) 63
German (58) 58
Spanish (50) 50
Korean (31) 31
Italian (15) 15
Polish (11) 11
Chinese (9) 9
Dutch (8) 8
Norwegian (5) 5
Russian (5) 5
Ukrainian (5) 5
Portuguese (4) 4
Bulgarian (2) 2
Czech (2) 2
Danish (2) 2
Hungarian (2) 2
Arabic (1) 1
Croatian (1) 1
Finnish (1) 1
Hebrew (1) 1
Icelandic (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 04/2016, Volume 315, Issue 15, pp. 1580 - 1590
Journal Article
Disease markers, ISSN 0278-0240, 2019, Volume 2019, pp. 2984747 - 11
Because tandem mass spectrometry- (MS/MS-) based newborn screening identifies many suspicious cases of fatty acid oxidation and carnitine cycle disorders, a... 
MEDICINE, RESEARCH & EXPERIMENTAL | MEDIUM-CHAIN | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | LIVER | GENETICS & HEREDITY | COA DEHYDROGENASE-DEFICIENCY | DISORDERS | PATHOLOGY | TANDEM MASS-SPECTROMETRY | FIBROBLASTS | ENZYMATIC DIAGNOSIS | Molecular Diagnostic Techniques - methods | Nervous System Diseases - blood | Humans | Infant | Monocytes - metabolism | Mitochondrial Myopathies - blood | Adult | Acyl-CoA Dehydrogenase, Long-Chain - blood | Carnitine - analogs & derivatives | Carnitine O-Palmitoyltransferase - deficiency | Fatty Acids - metabolism | Cardiomyopathies - blood | Oxidation-Reduction | Lipid Metabolism, Inborn Errors - blood | Mitochondrial Trifunctional Protein - blood | Deuterium - chemistry | Carnitine - chemistry | Biomarkers - blood | Muscular Diseases - blood | Monocytes - chemistry | Rhabdomyolysis - blood | Mitochondrial Diseases - blood | Mass Spectrometry - methods | Acyl-CoA Dehydrogenase, Long-Chain - deficiency | Mitochondrial Trifunctional Protein - deficiency | Deuterium | Pediatrics | Dehydrogenases | Enzyme activity | Liver | Disorders | Leukocytes (mononuclear) | Blood | Acyl-CoA dehydrogenase | Defects | Proteins | Enzymatic activity | Lymphocytes | Fibroblasts | Peripheral blood mononuclear cells | Oxidation | Diagnosis | Enzymes | Mass spectroscopy | Protein deficiency | Metabolism | Palmitoyltransferase | Medical screening | Fatty acids | Patients | Chromatography | Carnitine palmitoyltransferase | Carnitine | Scientific imaging | Diagnostic systems | Mutation | Mass spectrometry | Viability
Journal Article
Journal of Strength and Conditioning Research, ISSN 1064-8011, 07/2016, Volume 30, Issue 7, pp. 2064 - 2068
Journal Article
Clinical Journal of Sport Medicine, ISSN 1050-642X, 11/2018, Volume 28, Issue 6, pp. 491 - 492
Journal Article
Journal Article
Journal of Inherited Metabolic Disease, ISSN 0141-8955, 3/2015, Volume 38, Issue 2, pp. 315 - 322
Children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD) have a defect in the degradation of long-chain fatty acids and are at risk of... 
Human Genetics | Biochemistry, general | Pediatrics | Internal Medicine | Medicine & Public Health | Metabolic Diseases | COA DEHYDROGENASE | GROWTH-HORMONE | INSULIN-RESISTANCE | FATTY-ACID | ENDOCRINOLOGY & METABOLISM | GENETICS & HEREDITY | TRIFUNCTIONAL PROTEIN-DEFICIENCY | GLYCEMIC RESPONSE | INDUCED HYPOGLYCEMIA | ACID OXIDATION DISORDERS | ADIPOSE-TISSUE | GLUCOSE-PRODUCTION | Nervous System Diseases - enzymology | 3-Hydroxyacyl CoA Dehydrogenases - blood | Lipid Metabolism, Inborn Errors - diet therapy | Nervous System Diseases - blood | Rhabdomyolysis - enzymology | Age Factors | Humans | Child, Preschool | Male | Cardiomyopathies - enzymology | Lipid Metabolism, Inborn Errors - enzymology | Nervous System Diseases - diagnosis | Mitochondrial Myopathies - blood | Rhabdomyolysis - diagnosis | Rhabdomyolysis - diet therapy | Hyperglycemia - diagnosis | Time Factors | Fasting - blood | Cardiomyopathies - diagnosis | Postprandial Period | Isotope Labeling | Female | Carnitine - analogs & derivatives | Mitochondrial Myopathies - diagnosis | Child | Cardiomyopathies - blood | Cardiomyopathies - diet therapy | Lipid Metabolism, Inborn Errors - blood | Lipid Metabolism, Inborn Errors - diagnosis | Carnitine - blood | Calorimetry, Indirect | Biomarkers - blood | Nervous System Diseases - diet therapy | Mitochondrial Myopathies - diet therapy | Lipolysis | Microdialysis | Energy Metabolism | Hyperglycemia - blood | Mitochondrial Myopathies - enzymology | Hyperglycemia - enzymology | 3-Hydroxyacyl CoA Dehydrogenases - deficiency | Glycerol - blood | Rhabdomyolysis - blood | Blood Glucose - metabolism | Mitochondrial Trifunctional Protein - deficiency | Fatty acids | Dextrose | Glucose | Index Medicus | Clinical Medicine | Medical and Health Sciences | Endokrinologi och diabetes | Klinisk medicin | Medicin och hälsovetenskap | Endocrinology and Diabetes
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0172965
Purpose Exertional rhabdomyolysis can occur in individuals performing various types of exercise but it is unclear why some individuals develop this condition... 
POLYMORPHISMS | PERFORMANCE | MULTIDISCIPLINARY SCIENCES | INJURY | ACTN3 GENOTYPE | EXERCISE | INDUCED MUSCLE DAMAGE | Myosin-Light-Chain Kinase - genetics | Prognosis | Humans | Middle Aged | Tumor Necrosis Factor-alpha - blood | Tumor Necrosis Factor-alpha - genetics | Male | Gene Expression Profiling | Peptidyl-Dipeptidase A - genetics | Rhabdomyolysis - diagnosis | Insulin-Like Growth Factor II - genetics | Peptidyl-Dipeptidase A - blood | Interleukin-6 - blood | Actinin - genetics | Rhabdomyolysis - pathology | Adult | Female | Creatine Kinase, MM Form - blood | Physical Exertion | Creatine Kinase, MM Form - genetics | Interleukin-6 - genetics | Gene Expression Regulation | Insulin-Like Growth Factor II - metabolism | Actinin - blood | Rhabdomyolysis - genetics | Adolescent | Running | Myosin-Light-Chain Kinase - blood | Aged | Polymorphism, Single Nucleotide | Rhabdomyolysis - blood | Myoglobin - blood | Creatine kinase | Runners (Sports) | Genetic aspects | Research | Rhabdomyolysis | Single nucleotide polymorphisms | Marathon running | Health aspects | Risk factors | Myoglobin | Physical training | Laboratories | Anthropometry | Single-nucleotide polymorphism | Insulin-like growth factors | Creatine | Kinases | Myosin-light-chain kinase | Training | Interleukin 6 | Proteins | Signal transduction | Vitamin E | Rodents | Race | Genetics | Tumor necrosis factor-TNF | Insulin-like growth factor II | Genotypes | Enzymes | Cytokines | Muscles | Tumor necrosis factor-α | Metabolism | Gene expression | Musculoskeletal system | Physical fitness | Exercise physiology | Habits | Endocrinology
Journal Article
Journal Article
Atherosclerosis, ISSN 0021-9150, 2012, Volume 221, Issue 1, pp. 169 - 175
Highlights ► Rosuvastatin–fenofibrate combination and rosuvastatin monotherapy were compared. ► We randomized 180 Asians with mixed hyperlipidemia with 24-week... 
Cardiovascular | Fenofibrate | Rosuvastatin | Safety | Asia | Creatine kinase | GEMFIBROZIL | METABOLIC SYNDROME | ACID | RANDOMIZED CONTROLLED-TRIAL | RHABDOMYOLYSIS | ATORVASTATIN | STATIN | PERIPHERAL VASCULAR DISEASE | DYSLIPIDEMIA | TYPE-2 DIABETES-MELLITUS | Hyperlipidemias - blood | Blood Urea Nitrogen | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Fenofibrate - adverse effects | Hyperlipidemias - ethnology | Liver - drug effects | Time Factors | Muscle, Skeletal - drug effects | Cardiovascular Diseases - blood | Chemical and Drug Induced Liver Injury - blood | Cardiovascular Diseases - etiology | Hypolipidemic Agents - adverse effects | Muscle, Skeletal - enzymology | Risk Assessment | Risk Factors | Rosuvastatin Calcium | Biomarkers - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Creatinine - blood | Rhabdomyolysis - chemically induced | Hypolipidemic Agents - therapeutic use | Blood Glucose - metabolism | Liver - enzymology | Cardiovascular Diseases - ethnology | Fenofibrate - therapeutic use | Patient Selection | Lipids - blood | Female | Republic of Korea - epidemiology | Chemical and Drug Induced Liver Injury - etiology | Hyperlipidemias - complications | Hyperlipidemias - drug therapy | Hemoglobins - metabolism | Homocysteine - blood | Treatment Outcome | Asian Continental Ancestry Group | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Aged | Fluorobenzenes - adverse effects | Rhabdomyolysis - blood | Enzymes - blood | Drug Combinations | Fluorobenzenes - therapeutic use | Enzymes | Medical colleges | Care and treatment | National health insurance | Hyperlipidemia | Atherosclerosis | Cardiology | Homocysteine | Creatine | Fibric acids | Index Medicus
Journal Article